Myomo outlines 10% revenue growth target for 2026 while expanding recurring patient sources and international operations
Source: SeekingAlpha
2026-03-09 19:08:45 ET
More on Myomo
- Myomo, Inc. (MYO) Q4 2025 Earnings Call Transcript
- Myomo Non-GAAP EPS of -$0.37 misses by $0.28, revenue of $11.4M beats by $1M
- Seeking Alpha’s Quant Rating on Myomo
- Historical earnings data for Myomo
- Financial information for Myomo
Read the full article on Seeking Alpha
For further details see:
Myomo outlines 10% revenue growth target for 2026 while expanding recurring patient sources and international operations
Myomo Inc.
NASDAQ: MYO
MYO Trading
1.85% G/L:
$0.7204 Last:
154,628 Volume:
$0.7172 Open:
MYO Latest News
March 09, 2026 04:06:00 pm
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 09, 2026 04:05:00 pm
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
MYO Stock Data
$31,609,375
36,594,462
4.42%
23
N/A
Medical Equipment & Supplies
Healthcare
US
Burlington
